Drug Topics January 2020

Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.

Quality, speed, and price has been referred to as the "Unattainable Triangle".

As we head into a new year, Drug Topics® is exploring some of the latest pharmacy trends and how they will shape the industry in the next decade. 

Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.

Let’s take a look at some of the most common issues pharmacists are facing, as seen recently on Facebook.

Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications. 

Here are 4 pharmacy-related New Year’s resolutions that can help enhance your pharmacy services.

The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.

Progress has been made, but there’s still a long road ahead.

Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.

Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.

Here are the top drugs expected to be approved this year.

RDTs can improve outcomes and reduce unnecessary antibiotic use. 

Results from a poster at ASHP 2019.